News

Press Release: Ovarian Cancer Advocates Applaud Findings on...

Press Release: Ovarian Cancer Advocates Applaud Findings on Aspirin and Risk Reduction

February 7, 2014

FOR IMMEDIATE RELEASE: February 7, 2014 Further Study Needed Before Clinical Recommendations Change Washington, DC—A study published yesterday by the National Institutes of Health found that women who took aspirin on a daily basis had a 20 percent reduction in risk of ovarian cancer. The Ovarian Cancer National Alliance released the following statement in response … Continued

Study Shows 1 in 5 Women with Ovarian Cancer has Inherited ...

Study Shows 1 in 5 Women with Ovarian Cancer has Inherited Predisposition

January 31, 2014

(January 31, 2014)  A new study conservatively estimates that one in five women with ovarian cancer has inherited genetic mutations that increase the risk of the disease, according to research at Washington University School of Medicine in St. Louis. Most women in the study would have been unaware of a genetic predisposition to ovarian cancer because … Continued

OCRF Research Finds New Factor in Ovarian Cancer Development

OCRF Research Finds New Factor in Ovarian Cancer Development

January 30, 2014

  (January 30, 2014)  OCRF grantee Yin Wang, PhD, led research which found that PKC iota signaling plays an important role in ovarian cancer development. The research, which was published in Molecular Cancer Research, also found that Auranofin,  a small molecular compound, shows potential for treating ovarian cancer. The research study was funded in part by … Continued

1 in 5 women with ovarian cancer have a genetic predisposition

1 in 5 women with ovarian cancer have a genetic predisposition

January 28, 2014

At least 20% of women with ovarian cancer have a genetic predisposition to the disease even if they don’t have a family history ovarian cancer, according to a recent study. Researchers at Washington University School of Medicine in St. Louis analyzed the genes in ovarian cancer tumor samples from over 400 women with no family … Continued

2014 Ovarian Cancer Statistics

2014 Ovarian Cancer Statistics

January 22, 2014

(January 22, 2014) Each year, the American Cancer Society estimates the numbers of new cancer cases and deaths that will occur in the United States in the current year and compiles the most recent data on cancer incidence, mortality, and survival. Incidence data were collected by the National Cancer Institute, the Centers for Disease Control … Continued

OCRFA Research Identifies Biomarker that May Predict Treatment Response

January 14, 2014

(January 13, 2014) Researchers at Case Western Reserve University, led by OCRFA grantee Analisa DiFeo, PhD have identified a microRNA biomarker that shows promise in predicting treatment response in the most common form of ovarian cancer – a finding that has the potential to improve outcomes for patients with the disease.  The findings were published … Continued

Ovarian Cancer Research Fund Awards a Record-Breaking $6.9 ...

Ovarian Cancer Research Fund Awards a Record-Breaking $6.9 Million in Grants

January 13, 2014

Kicks off 20th Anniversary with an unprecedented grant award for scientific research and gynecologic cancer patient support program New York, NY January 13, 2014 — To mark its 20th anniversary, Ovarian Cancer Research Fund has awarded a record-breaking $6.9 million in scientific research grants for ovarian cancer and program grants to support gynecologic cancer patients. … Continued

Meet OCRF’s 2014 Grant Recipients

Meet OCRF’s 2014 Grant Recipients

January 13, 2014

OCRF has awarded $6.5 million in research grants to 22 scientists at leading medical institutions across the country.

New combination therapy for ovarian cancer shows positive r...

New combination therapy for ovarian cancer shows positive results in Phase I clinical trials

January 7, 2014

A new combination therapy developed by researchers at the Roswell Park Cancer Institute has showed positive results in 60% of women with recurrent ovarian cancer. To develop the new therapy, researchers took advantage of the fact that ovarian cancer cells have abnormally high a marker called NY-ESO-1 on their surfaces. Researchers gave patients a drug … Continued

OCRF Research Finds New “Chemoimmunotherapy” Ma...

OCRF Research Finds New “Chemoimmunotherapy” May Be New Treatment Option

January 6, 2014

New research funded by OCRF shows that treatment with the drug decitabine, prior to administration of chemotherapy and a cancer vaccine, yielded clinical benefit for women with recurrent ovarian cancer. This suggests that this combinatorial “chemoimmunotherapy” may provide a new treatment option for patients with this disease. Results of this phase I clinical trial, which … Continued

New Guidelines on Risk, Genetic Counseling & Testing f...

New Guidelines on Risk, Genetic Counseling & Testing for BRCA-related Cancer

December 30, 2013

(December 30, 2013)   The U.S. Preventive Services Task Force (Task Force) has issued a final recommendation statement on Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-related Cancer in Women. This final recommendation statement applies to women who have no signs or symptoms of a BRCA-related cancer (cancer of the breast, ovary, fallopian tube, or … Continued

High Volume Hospitals and Providers Improve Survival

High Volume Hospitals and Providers Improve Survival

December 20, 2013

(December 20, 2013)  Researchers have found that for women with advanced-stage ovarian cancer, being treated at a high volume hospital with a high volume provider, leads to improved survival.  The research was published online today in Gynecologic Oncology. Among patients with advanced-stage ovarian cancer, the provider combination of high volume hospital/high volume provider is an … Continued